14-day Premium Trial Subscription Sign Up For FreeGet Free

ANI Pharmaceuticals Stock Forecast NASDAQ:ANIP

$39.55 (-3.54%)

Volume: 113k

Closed: Dec 03, 2021

Hollow Logo Score: -1.532

ANI Pharmaceuticals Stock Forecast

$39.55 (-3.54%)

Volume: 113k

Closed: Dec 03, 2021

Score Hollow Logo -1.532
Which way will ANIP go? Request
Key Stats
P/E Ratio -22.80
Beta 1.19
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 27 and the stock is currently not being overbought or oversold

Red day on Friday for ANI Pharmaceuticals stock after losing 3.54%
(Updated on Dec 03, 2021)


Sell candidate since 2021-12-02 Loss -3.54%

The ANI Pharmaceuticals stock price fell by -3.54% on the last day (Friday, 3rd Dec 2021) from $41.00 to $39.55. During the day the stock fluctuated 6.28% from a day low at $39.19 to a day high of $41.65. The price has been going up and down for this period, and there has been a -8.77% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -43 thousand shares and in total, 113 thousand shares were bought and sold for approximately $4.46 million.

Given the current short-term trend, the stock is expected to rise 44.93% during the next 3 months and, with a 90% probability hold a price between $57.32 and $92.58 at the end of this 3-month period.

Signals & Forecast

There are few to no technical positive signals at the moment. The ANI Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $40.98 and $43.37. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 02, 2021, and so far it has fallen -30.43%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

ANI Pharmaceuticals finds support from accumulated volume at $38.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.46 between high and low, or 6.28%. For the last week, the stock has had a daily average volatility of 5.62%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is ANI Pharmaceuticals stock A Buy?

The ANI Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe ANI Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.532

Predicted Opening Price for ANI Pharmaceuticals of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$40.13 $39.55 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 02, 2021 "Truist Securities" gave "$70.00" rating for ANIP. The price target was set to $55.89+49.5%.

Volatility and Risk
Daily Average Volatility: 5.62 %
Overall Risk: Very High High Medium Low Very Low
Volatility
5.62 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $45.01
Price: $39.55
Support: $38.54

ANIP Insider Trading Show all Trades

INSIDER POWER

10.952

Last 100 transactions
Buy: 2 558 714 | Sell: 233 630 (Shares)
Date Action Amount Person Type
Nov 19, 2021 Buy 383 226 Gassert Chad Common Stock
Nov 19, 2021 Buy 1 332 620 Shanmugam Muthusamy Common Stock
Nov 19, 2021 Buy 13 460 Shanmugam Muthusamy Common Stock
Sep 08, 2021 Sell 2 577 Lalwani Nikhil Common Stock
Apr 12, 2021 Sell 3 042 Carey Stephen P. Common Stock
Show all Insider Trades
INSIDER POWER

10.952

Last 100 transactions
Buy: 2 558 714 | Sell: 233 630 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 42.59 7.69 %
41.65 5.31 %
41.07 3.84 %
Current price: 39.55
Support 39.19 -0.91 %
38.61 -2.38 %
37.67 -4.75 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 45.89 16.03 %
45.32 14.59 %
45.01 13.81 %
Current price 39.55
Support 38.54 -2.55%
37.38 -5.49%
31.95 -19.22%

Click to get the best stock tips daily for free!

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. The company focuses on producing controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It offers Esterified Estrogen with Methyltestosterone for use in treating vasomotor symptoms of menopause; Etodolac used to treat pain caused by oste... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT